Buprenorphine Transdermal Matrix Patch

Known as: Transdermal Buprenorphine 
A transdermal matrix patch containing the synthetic opioid buprenorphine with analgesic and sedative activities. Buprenorphine binds to and activates… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.
Buprenorphine was not used widely in clinical practice over many years, mainly due to analgesic potency and clinical safety… (More)
Is this relevant?
Review
2008
Review
2008
Management of chronic pain in the elderly: focus on transdermal buprenorphine
Chronic pain in the elderly is a significant problem. Pharmacokinetic and metabolic changes associated with increased age makes… (More)
Is this relevant?
2008
2008
Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain.
Strong opioids are recommended for treating severe cancer pain in the advanced stages of the disease. Few data are available… (More)
Is this relevant?
2007
2007
Use of a transdermal matrix patch of buprenorphine in cats: preliminary pharmacokinetic and pharmacodynamic data.
Six domestic shorthair cats, aged three to four years and weighing 5.1 to 7.4 kg, were used to assess the thermal antinociceptive… (More)
Is this relevant?
Review
2006
Review
2006
Transdermal buprenorphine in cancer pain and palliative care.
Transdermal buprenorphine has been assessed as a therapy for chronic cancer and non-cancer pain in both clinical and… (More)
  • figure 2
  • figure 1
  • table 1
  • table 2
  • figure 3
Is this relevant?
2006
2006
Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
BACKGROUND Transdermal buprenorphine is available in Europe for the treatment of moderate to severe chronic pain. It has been… (More)
Is this relevant?
2006
2006
Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine.
The present study was designed to study the impact of intermittent hemodialysis on the disposition of the partial agonist… (More)
Is this relevant?
2005
2005
Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
BACKGROUND The equipotency ratio of transdermal (TD) fentanyl to oral morphine has been established as 1:100; for buprenorphine… (More)
Is this relevant?
Review
2003
Review
2003
Transdermal Buprenorphine
▴ Buprenorphine is a low molecular weight, lipophilic, opioid analgesic. Recently, a transdermal matrix patch formulation of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind…
BACKGROUND Buprenorphine is a potent opioid analgesic that is available in sublingual and parenteral formulations. A new… (More)
Is this relevant?